This week, we speak to Lorena Kuri, Director of Clinical Trial Diversity Strategy, Bristol-Myers-Squibb, who discusses how to address underrepresentation in clinical trials, how teams can prioritise belonging, and how her experience as a board member of WOCIP has shaped her perspective and ambitions.
